来自Trichosanthes kirilowii的多糖化合物Maxim可以改善小鼠的二氧酸盐诱导的功能性便秘
Min Jiang1,2, Chuangchuang Wang1,2, Jian Chen3
1School of Pharmaceutical Sciences, Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in microbiology
|October 9, 2025
概括
特里科桑斯基里洛维多糖 (TKP) 通过改善肠道通道和减少炎症,有效地治疗小鼠的功能性便秘. 它还积极调节神经递质,氧化应激和肠道微生物群,支持其治疗潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 特里科桑提斯基里洛维麦克西姆 (Trichosanthes kirilowii Maxim) 已知可以缓解便秘.
- 多糖具有治疗性潜力,可以治疗便秘.
- 对Trichosanthes kirilowii多糖 (TKP) 对功能性便秘的预防作用和机制尚不清楚.
研究的目的:
- 研究TKP对功能性便秘的预防作用.
- 阐明TKP在改善便秘的潜在机制.
主要方法:
- 建立了diphenoxylate诱导的功能性便秘的小鼠模型.
- 评估了TKP对便分泌,肠道炎症,神经递质分泌和肠道微生物群的松作用.
主要成果:
- TKP改善了胃肠道过境和排便.
- TKP调节了神经递质水平,减少了氧化应激,并抑制了炎症类细胞因子.
- TKP增加了短链脂肪酸,并恢复了肠道微生物群平衡.
结论:
- 在小鼠中,TKP改善了功能性便秘.
- TKP为开发新的便秘治疗方法提供了药理学基础.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
717
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
717
Drugs for Treatment of Diarrhea-Predominant IBS
631
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
631
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
526
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
526
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
569
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
569
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
617
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
617
Drugs Affecting GI Tract Motility: Other Laxatives
1.0K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.0K


